Percutaneous Valvular and Structural Heart Disease Interventions. 2024 Core Curriculum of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC in collaboration with the European Association of Cardiovascular Imaging (EACVI) and the Cardiovascular Surgery Working Group (WG CVS) of the European Society of Cardiology

被引:0
作者
Teles, Rui Campante [1 ]
Van Belle, Eric [2 ]
Parma, Radoslaw [3 ]
Tarantini, Giuseppe [4 ]
Van Mieghem, Nicolas [5 ]
Mylotte, Darren [6 ,7 ]
Silva, Joana Delgado [8 ]
O'Connor, Stephen [9 ]
Sondegaard, Lars [10 ]
Luz, Andre [11 ]
Amat-Santos, Ignacio Jesus [12 ]
Arzamendi, Dabit
Blackman, Daniel [13 ,14 ]
De Backer, Ole [10 ]
Kunadian, Vijay [15 ,16 ]
Buchanan, Gill Louise [17 ]
MacCarthy, Phil [18 ]
Lurz, Philipp [19 ]
Naber, Christopher [20 ]
Chieffo, Alaide [21 ,22 ]
Paradies, Valeria [23 ]
Gilard, Martine [24 ]
Vincent, Flavien [2 ]
Fraccaro, Chiara [4 ]
Mehilli, Julinda [25 ]
Giannini, Cristina [26 ]
Silva, Bruno [27 ]
Poliacikova, Petra [28 ]
Karam, Nicole [29 ]
Veulemans, Verena [30 ]
Thiele, Holger [31 ]
Pilgrim, Thomas [32 ]
van Wely, Marleen [33 ]
James, Stefan [34 ,35 ]
Schmidt, Michael Rahbek [36 ]
Uebing, Anselm [37 ,38 ]
Ruck, Andreas [39 ]
Ghanem, Alexander [40 ]
Ghazzal, Ziyad [41 ]
Joshi, Francis R. [10 ,42 ]
Favero, Luca [43 ]
Hermanides, Renicus [44 ]
Ninios, Vlasis [45 ]
Fovino, Luca Nai [4 ]
Nuis, Rutger-Jan [5 ]
Deharo, Pierre [46 ]
Kala, Petr [47 ,48 ]
Elbaz-Greener, Gabby [49 ]
Tchetche, Didier [50 ]
Agricola, Eustachio [51 ]
机构
[1] Nova Med Sch, Hosp Santa Cruz, Ctr Hosp Lisboa Ocidental, Carnaxide & Comprehens Hlth Res Ctr CHRC, Ave Prof Reinaldo Santos, P-2790134 Lisbon, Portugal
[2] Univ Lille, Inst Coeur Poumon, CHU Lille, Cardiol, Lille, France
[3] Med Univ Silesia, Dept Cardiol & Struct Heart Dis, Katowice, Poland
[4] Univ Padua, Dept Cardiac Thorac & Vasc Sci & Publ Hlth, Intervent Cardiol, Padua, Italy
[5] Erasmus MC, Intervent Cardiol, Rotterdam, Netherlands
[6] Univ Hosp, Dept Cardiol, Galway, Ireland
[7] Natl Univ Ireland, Galway, Ireland
[8] Coimbra Hosp & Univ Ctr, Dept Cardiol, Cardiovasc Intervent Unit, Coimbra, Portugal
[9] St James Hosp, Cardiol Unit, Dublin, Ireland
[10] Copenhagen Univ Hosp, Dept Cardiol, Rigshosp, Copenhagen, Denmark
[11] Ctr Hosp Univ Porto, Porto, Portugal
[12] Hosp Clin Univ, Dept Cardiol, Valladolid, Spain
[13] Hosp Santa Creu & Sant Pau, Dept Cardiol, Barcelona, Spain
[14] Leeds Teaching Hosp, Leeds, England
[15] Newcastle Univ, Translat & Clin Res Inst, Fac Med Sci, Newcastle Upon Tyne, England
[16] Newcastle Tyne Hosp NHS Fdn Trust, Freeman Hosp, Cardiothorac Ctr, Newcastle Upon Tyne, England
[17] North Cumbria Integrated Care NHS Fdn Trust, Dept Cardiol Cumberland Infirm, Carlisle, England
[18] Kings Coll Hosp London, London, England
[19] Johannes Gutenberg Univ Mainz, Dept Cardiol, Mainz, Germany
[20] Facharztpraxis Baldeney Kardiol & Innere Med, Essen, Germany
[21] Ist Sci San Raffaele, Intervent Cardiol Unit, Milan, Italy
[22] Univ Vita Salute San Raffaele, Milan, Italy
[23] Maasstad Hosp, Rotterdam, Netherlands
[24] CHU Cavale Blanche, Dept Cardiol, Brest, France
[25] Hosp Landshut Achdorf, Dept Cardiol Pulmonol & Intens Med, Landshut, Germany
[26] Azienda Osped Univ Pisana, SD Emodinam, Pisa, Italy
[27] Hosp Cent Funchal, Cardiol Dept, Madeira, Portugal
[28] Cent Slovakia Inst Cardiovasc Dis, Banska Bystrica, Slovakia
[29] Hop Europeen Georges Pompidou, Dept Cardiol, Paris, France
[30] Univ Heart & Vasc Ctr Frankfurt, Frankfurt, Germany
[31] Univ Leipzig, Leipzig Heart Ctr, Internal Med Cardiol, Leipzig, Germany
[32] Univ Bern, Bern Univ Hosp, Dept Cardiol, Inselspital, Bern, Switzerland
[33] Radboud UMC, Dept Cardiol, Nijmegen, Netherlands
[34] Uppsala Univ, Dept Med Sci, Uppsala, Sweden
[35] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden
[36] Rigshosp, Dept Cardiol, Adult Congenital Heart Dis Unit, Copenhagen, Denmark
[37] Univ Hosp Schleswig Holstein, Dept Congenital & Paediat Cardiol, Campus Kiel, Kiel, Germany
[38] German Ctr Cardiovasc Res, Partner Site Kiel, Kiel, Germany
[39] Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden
[40] Asklepios Klin Nord Heidberg, Hamburg, Germany
[41] Amer Univ Beirut, Beirut, Lebanon
[42] Golden Jubilee Natl Hosp, Clydebank, Scotland
[43] Ca Foncello Reg Hosp, Cardiovasc Dept, Treviso, Italy
[44] Isala Hosp, Dept Cardiol, Isala Heart Ctr, Zwolle, Netherlands
[45] Interbalkan European Med Ctr, Cardiol Dept, Thessaloniki, Greece
[46] Hop La Timone, Dept Cardiol, Marseille, France
[47] Univ Hosp Brno, Dept Internal Med & Cardiol, Brno, Czech Republic
[48] Masaryk Univ, Dept Internal Med & Cardiol, Med Fac, Brno, Czech Republic
[49] Hebrew Univ Jerusalem, Hadassah Med Ctr, Jerusalem, Israel
[50] Clin Pasteur, Grp Cardiovasc Intervent, Toulouse, France
关键词
aortic stenosis; atrial fibrillation; hypertrophic cardiomyopathy; imaging modalities; mitral regurgitation; training and education; END-POINT DEFINITIONS; POSITION PAPER; TRANSCATHETER; MANAGEMENT; CONSENSUS;
D O I
10.4244/EIJ-D-23-00983
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The percutaneous treatment of structural, valvular, and non-valvular heart disease (SHD) is rapidly evolving. The Core Curriculum (CC) proposed by the EAPCI describes the knowledge, skills, and attitudes that define competency levels required by newly trained SHD interventional cardiologists (IC) and provides guidance for training centres. SHD ICs are cardiologists who have received complete interventional cardiology training. They are multidisciplinary team specialists who manage adult SHD patients from diagnosis to follow-up and perform percutaneous procedures in this area. They are competent in interpreting advanced imaging techniques and master planning software. The SHD ICs are expected to be proficient in the aortic, mitral, and tricuspid areas. They may have selective skills in either the aortic area or mitral/tricuspid areas. In this case, they must still have common transversal competencies in the aortic, mitral, and tricuspid areas. Additional SHD domain competencies are optional. Completing dedicated SHD training, aiming for full aortic, mitral, and tricuspid competencies, requires at least 18 months. For full training in the aortic area, with basic competencies in mitral/tricuspid areas, the training can be reduced to 1 year. The same is true for training in the mitral/tricuspid area, with competencies in the aortic area. The SHD IC CC promotes excellence and homogeneous training across Europe and is the cornerstone of future certifications and patient protection. It may be a reference for future CC for national associations and other SHD specialities, including imaging and cardiac surgery.
引用
收藏
页码:1370 / 1379
页数:10
相关论文
共 20 条
  • [1] Van Belle E, Teles RC, Pyxaras SA, Kalpak O, Johnson TW, Barbash IM, De Luca G, Kostov J, Parma R, Vincent F, Brugaletta S, Debry N, Toth GG, Ghazzal Z, Deharo P, Milasinovic D, Kaspar K, Saia F, Mauri Ferre J, Kammler J, Muir DF, O'Connor S, Mehilli J, Thiele H, Weilenmann D, Witt N, Joshi F, Kharbanda RK, Piroth Z, Wojakowski W, Geppert A, Di Gioia G, Pires-Morais G, Petronio AS, Estevez-Loureiro R, Ruzsa Z, Kefer J, Kunadian V, Van Mieghem N, Windecker S, Baumbach A, Haude M, Dudek D., EAPCI
  • [2] Agricola E, Ancona F, Brochet E, Donal E, Dweck M, Faletra F, Lancellotti P, Mahmoud-Elsayed H, Marsan NA, Maurovich-Hovart P, Monaghan M, Ribeiro J, Sade LE, Swaans M, Von Bardeleben RS, Wunderlich N, Zamorano JL, Popescu BA, Cosyns B, Edvardsen T, Reviewers: This document was reviewed by members of the 2018-2020 EACVI Scientific Documents Committee. The structural heart disease interventional imager rationale, skills and training: a position paper of the European Association of Cardiovascular
  • [3] Leonardi S, Capodanno D, Sousa-Uva M, Vrints C, Rex S, Guarracino F, Bueno H, Lettino M, Price S, Valgimigli M, Jeppsson A., Composition, structure, and function of heart teams: a joint position paper of the ACVC, EAPCI, EACTS, and EACTA focused on the management of patients with complex coronary artery disease requiring myocardial revascularization, Eur Heart J Acute Cardiovasc Care, 10, pp. 83-93, (2021)
  • [4] Parma R, Zembala MO, Dabrowski M, Jagielak D, Witkowski A, Suwalski P, Dudek D, Olszowka P, Wojakowski W, Przybylski R, Gil R, Kusmierczyk M, Lesiak M, Sadowski J, Dobrzycki S, Ochala A, Hoffman P, Kapelak B, Kazmierczak J, Jasinski M, Stepinska J, Szymanski P, Hryniewiecki T, Kochman J, Grygier M, Zembala M, Legutko J, Rozanski J., Transcatheter aortic valve implantation. Expert Consensus of the Association of Cardiovascular Interventions of the Polish Cardiac Society and the Polish Society of
  • [5] Loureiro-Ga M, Veiga C, Fdez-Manin G, Jimenez VA, Juan-Salvadores P, Busto L, Baz JA, Iniguez A., Predicting TAVI paravalvular regurgitation outcomes based on numerical simulation of the aortic annulus eccentricity and perivalvular areas, Comput Methods Biomech Biomed Engin, 24, pp. 1629-1637, (2021)
  • [6] Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Rodriguez Munoz D, Rosenhek R, Sjogren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL, 2017 ESC/EACTS Guidelines for the management of valvular heart disease, Eur Heart J, 38, pp. 2739-2791, (2017)
  • [7] Lorenzoni V, Barbieri G, Saia F, Meucci F, Martinelli GL, Cerillo AG, Berti S, Candolfi P, Turchetti G., The cost-effectiveness of transcatheter aortic valve implantation: exploring the Italian National Health System perspective and different patient risk groups, Eur J Health Econ, 22, pp. 1349-1363, (2021)
  • [8] Pongiglione B, Torbica A, Blommestein H, de Groot S, Ciani O, Walker S, Dams F, Blankart R, Mollenkamp M, Kovacs S, Tarricone R, Drummond M., Do existing real-world data sources generate suitable evidence for the HTA of medical devices in Europe? Mapping and critical appraisal, Int J Technol Assess Health Care, 37, (2021)
  • [9] Saad AM, Kassis N, Isogai T, Gad MM, Ahuja KR, Abdelfattah O, Shekhar S, Farwati M, Yun JJ, Krishnaswamy A, Svensson LG, Kapadia S., Trends in Outcomes of Transcatheter and Surgical Aortic Valve Replacement in the United States (2012-2017), Am J Cardiol, 141, pp. 79-85, (2021)
  • [10] Genereux P, Piazza N, Alu MC, Nazif T, Hahn RT, Pibarot P, Bax JJ, Leipsic JA, Blanke P, Blackstone EH, Finn MT, Kapadia S, Linke A, Mack MJ, Makkar R, Mehran R, Popma JJ, Reardon M, Rodes-Cabau J, Van Mieghem NM, Webb JG, Cohen DJ, Leon MB., Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research, Eur Heart J, 42, pp. 1825-1857, (2021)